Ph.D. Alan J. Main

Insider Reports History

SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Alan J. Main, Ph.D.
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Ph.D. Alan J. Main

Form 4 holding EVP, Innov & Chem Sciences

LEXICON PHARMACEUTICALS, INC.

Security class
Common Stock
Shares / value
339,104
Estimated value
$227,200
Report date
28 Feb 2025
Price
$0.6700
Ownership
Direct
Form 4 holding EVP, Innov & Chem Sciences

LEXICON PHARMACEUTICALS, INC.

Security class
Restricted Stock Units
Shares / value
136,487
Estimated value
$91,446
Report date
28 Feb 2025
Price
$0.6700
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding EVP, Innov & Chem Sciences

LEXICON PHARMACEUTICALS, INC.

Security class
Stock Option (Right to Buy)
Shares / value
753,090
Estimated value
Report date
13 Feb 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Ph.D. Alan J. Main

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .